查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679199

2030 年透明质酸市场预测：按产品、配方、分销管道、应用、最终用户和地区进行的全球分析

Hyaluronic Acid Market Forecasts to 2030 - Global Analysis By Product, Formulation, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球透明质酸市场规模预计在 2024 年达到 15.2 亿美元，到 2030 年将达到 27.1 亿美元，预测期内的复合年增长率为 9.8%。

透明质酸是一种天然物质，主要存在于结缔组织、皮肤和关节中。玻尿酸是Glico，具有锁水、保湿、润滑和弹性的作用。 HA 被广泛用于改善皮肤水分、减少皱纹并使皮肤丰满。它还可以透过润滑关节来帮助治疗骨关节炎，并用于眼科手术。其保湿特性对于维持皮肤健康和整体组织功能至关重要。

根据国际骨关节炎研究协会 (OARSI) 的数据，大约 90% 的黏性补充补充剂处方都是用于治疗骨关节炎的皮质类固醇和透明质酸注射。

对抗衰老产品的需求不断增加

HA 是精华液、乳霜和真皮填充剂中的关键成分，具有锁住水分、减少皱纹和增加皮肤弹性的功效。人口老化日益加剧、美容意识不断增强以及对非侵入性美容治疗的偏好进一步推动了基于透明质酸的产品的销售。此外，护肤配方的进步和皮肤科医生的建议也增强了消费者的信心。化妆品行业的扩张、电子商务平台以及社交媒体的影响也推动了透明质酸市场的成长，使其成为主要的护肤成分。

潜在的副作用

透明质酸 (HA)，尤其是在皮肤填充剂等输液治疗中，会引起潜在的副作用，如发红、肿胀、过敏反应和感染疾病。在极少数情况下，不当给药会导致肿块、血管阻塞和填充物移位。此外，安全问题、不一致的结果以及需要重复治疗也不利于长期使用。这些风险引发消费者担忧和监管挑战，阻碍了市场成长。

在治疗骨关节炎的应用日益广泛

透明质酸注射剂被称为黏性补充补充剂，有助于润滑和缓衝关节、减轻疼痛并改善活动能力。由于人口老化和久坐的生活方式导致骨关节炎病例增加，对非手术和微创治疗的需求日益增长。持续的研究和开发进展以及 FDA核准正在提高产品的可用性和有效性。此外，基于HA的疗法提供了一种有效的止痛药和手术的替代方案，进一步鼓励了其被采用。

产品成本高

透明质酸的生产成本很高，因为它需要基于发酵的萃取、精製和品管过程。生产用于护肤或药物应用的医用级或高纯度 HA 需要先进的生物技术，这会增加製造成本。此外，研发投资、监管部门核准和专门的配方也会增加成本。这限制了可用性和可负担性，特别是在购买力较低的新兴市场，阻碍了整体市场的扩张。

COVID-19 的影响：

由于供应链中断、选择性手术减少以及消费者在化妆品上的支出减少，COVID-19 疫情最初扰乱了透明质酸市场。这些诊所的关闭导致了皮肤填充剂等美容疗程的减少。然而，疫情后的復苏导致对护肤、健康和微创手术的需求增加。此外，随着医疗系统恢復非紧急程序，包括骨关节炎和眼科护理在内的医疗领域也得到復苏，稳定了市场成长。

预计在预测期内，聚合透明质酸部分将成为最大的部分。

预计预测期内聚合透明质酸部分将占据最大的市场占有率。 HMW-HA 是一种具有较大分子链的透明质酸，通常超过 1,000 kDa。它可以保持水分，增加皮肤水分，并形成保护屏障，促进创伤治疗。它具有强大的抗炎特性，有助于减少氧化压力。它通常添加到护肤中，提供持久的保湿和丰盈效果。

预计预测期内个人护理和美容领域将出现最高的复合年增长率。

由于其出色的保湿和抗衰老特性，个人护理和美容领域预计将在预测期内见证最高增长率。它能吸引和保留水分，使肌肤看起来更丰满、更光滑、更年轻。它存在于精华液、乳霜和麵霜中，有助于减少细纹、增强弹性和舒缓粗糙的皮肤。其在世界各地的护肤和化妆品配方中的受欢迎程度持续增长。

占比最大的地区：

在预测期内，由于护肤意识的增强、抗衰老产品需求的增加以及医疗应用的不断扩大，预计亚太地区将占据最大的市场占有率。受美容产业蓬勃发展和美容程序高采用率的推动，中国、日本、韩国和印度等国家引领市场。该地区人口老化推动了对真皮填充剂和骨关节炎治疗的需求，而生物技术的进步则推动了产品创新。此外，韩国美容和日本美容趋势正在推动基于透明质酸的护肤的销售。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率，这主要得益于消费者对抗衰老护肤护肤、真皮填充剂和骨关节炎治疗的需求。美国凭藉其成熟的美容和保健行业、日益增强的美容意识以及微创手术的兴起在市场上占据主导地位。该地区也广泛采用基于 HA 的眼科和整形外科治疗。此外，主要产业参与者的存在和不断增加的研发投入进一步支持了市场的成长轨迹。

免费客製化服务：

透过订阅此报告，您将获得以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第 5 章 全球玻尿酸市场（依产品）

  • 高分子量玻尿酸
  • 中分子量透明质酸
  • 低分子量透明质酸

6. 全球玻尿酸市场（依配方）

  • 注射
  • 局部的
  • 口服

7. 全球透明质酸市场按分销管道划分

  • 电子商务平台
  • 超级市场/大卖场
  • 药局和药局
  • 专卖店
  • 其他分销管道

8. 全球玻尿酸市场（依应用）

  • 食品和补充品
  • 眼科
  • 整形外科
  • 药品
  • 个人护理及美容
  • 其他用途

第 9 章 全球玻尿酸市场（依最终用户划分）

  • 医院
  • 美容诊所
  • 生技公司
  • 研究所
  • 其他最终用户

第 10 章 全球玻尿酸市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Allergan Corporation
  • Sanofi Corporation
  • Evonik Industries AG
  • Bloomage Biotechnology Corporation Limited
  • Seikagaku Corporation
  • Anika Therapeutics, Inc.
  • LG Chem
  • Lubrizol Corporation
  • Royal DSM
  • Kewpie Corporation
  • Symatese Group
  • HTL Biotechnology
  • FocusChem Biotech
  • Croda International Plc
  • Stanford Chemicals Company
  • Maruha Nichiro Corporation
  • Evolus, Inc.
  • Contipro as
  • Fidia Farmaceutici SpA
  • Zimmer Biomet
Product Code: SMRC28782

According to Stratistics MRC, the Global Hyaluronic Acid Market is accounted for $1.52 billion in 2024 and is expected to reach $2.71 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Hyaluronic acid is a naturally occurring substance found in the human body, primarily in connective tissues, skin, and joints. It is a glycosaminoglycan known for its ability to retain water, providing hydration, lubrication, and elasticity. HA is widely used to improve skin hydration, reduce wrinkles, and enhance plumpness. It helps treat osteoarthritis by lubricating joints and is used in eye surgeries. Its moisture-binding properties make it essential for maintaining skin health and overall tissue function.

According to the Osteoarthritis Research Society International (OARSI), nearly 90% of visco supplement prescriptions consists of both corticosteroids and hyaluronic acid injections to treat osteoarthritis.

Market Dynamics:

Driver:

Rising demand for anti-aging products

HA is a key ingredient in serums, creams, and dermal fillers, known for its ability to retain moisture, reduce wrinkles, and enhance skin elasticity. The growing aging population, increasing beauty consciousness, and preference for non-invasive cosmetic treatments further boost HA-based product sales. Additionally, advancements in skincare formulations and endorsements by dermatologists fuel consumer trust. The expansion of the cosmetic industry, e-commerce platforms, and social media influence also accelerates HA market growth, making it a dominant skincare ingredient.

Restraint:

Potential side effects

Hyaluronic acid (HA) may cause potential side effects such as redness, swelling, allergic reactions, or infections, especially with injectable treatments like dermal fillers. In rare cases, improper administration can lead to lumps, vascular occlusion, or migration of fillers. Additionally, safety issues, inconsistent results, and the need for repeated treatments discourage long-term use. These risks create consumer concerns and regulatory challenges, hampering market growth.

Opportunity:

Growing use in osteoarthritis treatment

HA injections, known as visco supplementation, help lubricate and cushion joints, reducing pain and improving mobility. As osteoarthritis cases rise due to aging populations and sedentary lifestyles, demand for non-surgical, minimally invasive treatments increases. Ongoing R&D advancements and FDA approvals enhance product availability and effectiveness. Additionally, HA-based therapies offer an effective alternative to painkillers and surgeries, further boosting adoption.

Threat:

High product costs

Hyaluronic acid has high production costs due to its complex fermentation-based extraction, purification, and quality control processes. Producing medical-grade or high-purity HA for skincare and pharmaceutical applications requires advanced biotechnology, increasing manufacturing expenses. Additionally, R&D investments, regulatory approvals, and specialized formulations add to the cost. As a result, restricted accessibility and affordability hinder overall market expansion, especially in developing regions with lower purchasing power.

Covid-19 Impact:

The covid-19 pandemic initially disrupted the hyaluronic acid market due to supply chain interruptions, reduced elective procedures, and lower consumer spending on cosmetics. Lockdowns led to a decline in aesthetic treatments like dermal fillers. However, post-pandemic recovery saw increased demand for skincare, wellness, and minimally invasive procedures. Additionally, the medical segment, including osteoarthritis and ophthalmic treatments, rebounded as healthcare systems resumed non-urgent procedures, stabilizing market growth.

The high molecular weight hyaluronic acid segment is expected to be the largest during the forecast period

The high molecular weight hyaluronic acid segment is expected to account for the largest market share during the forecast period. HMW-HA is a form of hyaluronic acid with large molecular chains, typically above 1,000 kDa. It retains moisture, enhances skin hydration, and promotes wound healing by forming a protective barrier. It has strong anti-inflammatory properties and helps in reducing oxidative stress. Commonly found in skincare, it provides long-lasting hydration and plumping effects.

The personal care & beauty segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the personal care & beauty segment is predicted to witness the highest growth rate due to its exceptional hydrating and anti-aging properties. It attracts and retains moisture, making skin plumper, smoother, and more youthful. Found in serums, creams, and masks, it helps reduce fine lines, improves elasticity, and soothes irritation. Its popularity continues to grow in skincare and cosmetic formulations worldwide.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising skincare awareness, increasing demand for anti-aging products, and expanding medical applications. Countries like China, Japan, South Korea, and India lead the market, driven by a booming beauty industry and high adoption of cosmetic procedures. The region's aging population fuels demand for dermal fillers and osteoarthritis treatments, while advancements in biotechnology enhance product innovation. Additionally, the popularity of K-beauty and J-beauty trends boosts HA-based skincare sales.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by consumer demand for anti-aging skincare, dermal fillers, and osteoarthritis treatments. The U.S. dominates the market due to a well-established cosmetic and healthcare industry, increasing aesthetic consciousness, and rising minimally invasive procedures. The region also sees strong adoption of HA-based ophthalmic and orthopedic treatments. Additionally, the presence of key industry players and increasing R&D investments further support the market's growth trajectory.

Key players in the market

Some of the key players in Hyaluronic Acid market include Allergan Corporation, Sanofi Corporation, Evonik Industries AG, Bloomage Biotechnology Corporation Limited, Seikagaku Corporation, Anika Therapeutics, Inc., LG Chem, Lubrizol Corporation, Royal DSM, Kewpie Corporation, Symatese Group, HTL Biotechnology, FocusChem Biotech, Croda International Plc, Stanford Chemicals Company, Maruha Nichiro Corporation, Evolus, Inc., Contipro a.s., Fidia Farmaceutici S.p.A. and Zimmer Biomet.

Key Developments:

In October 2024, Evolus, Inc. announced that it received EU Medical Device Regulation (MDR) certification for four unique injectable hyaluronic acid (HA) gels under the brand name Estyme(R). This certification allows Evolus to enter the European dermal filler market, doubling its addressable market outside the U.S. to $1.8 billion.

In July 2024, Bloomage, a global leader in hyaluronic acid and bioactive substances, introduced MitoPQQ(TM) at the IFT FIRST Expo. This water-soluble compound, naturally found in various foods, enhances mitochondrial function, combats cellular aging, and supports cognitive health. Produced through fermentation, MitoPQQ(TM) is non-GMO and certified by GRAS, KOSHER, and HALAL standards.

Products Covered:

  • High Molecular Weight Hyaluronic Acid
  • Medium Molecular Weight Hyaluronic Acid
  • Low Molecular Weight Hyaluronic Acid

Formulations Covered:

  • Injectable
  • Topical
  • Oral

Distribution Channels Covered:

  • E-commerce Platforms
  • Supermarkets/Hypermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Other Distribution Channels

Applications Covered:

  • Food & Dietary Supplements
  • Ophthalmology
  • Orthopedics
  • Pharmaceuticals
  • Personal Care & Beauty
  • Other Applications

End Users Covered:

  • Hospitals
  • Aesthetic Clinics
  • Biotechnology Companies
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hyaluronic Acid Market, By Product

  • 5.1 Introduction
  • 5.2 High Molecular Weight Hyaluronic Acid
  • 5.3 Medium Molecular Weight Hyaluronic Acid
  • 5.4 Low Molecular Weight Hyaluronic Acid

6 Global Hyaluronic Acid Market, By Formulation

  • 6.1 Introduction
  • 6.2 Injectable
  • 6.3 Topical
  • 6.4 Oral

7 Global Hyaluronic Acid Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 E-commerce Platforms
  • 7.3 Supermarkets/Hypermarkets
  • 7.4 Pharmacies & Drug Stores
  • 7.5 Specialty Stores
  • 7.6 Other Distribution Channels

8 Global Hyaluronic Acid Market, By Application

  • 8.1 Introduction
  • 8.2 Food & Dietary Supplements
  • 8.3 Ophthalmology
  • 8.4 Orthopedics
  • 8.5 Pharmaceuticals
  • 8.6 Personal Care & Beauty
  • 8.7 Other Applications

9 Global Hyaluronic Acid Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Aesthetic Clinics
  • 9.4 Biotechnology Companies
  • 9.5 Research Institutions
  • 9.6 Other End Users

10 Global Hyaluronic Acid Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.10 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.10 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.1 Middle East & Africa
    • 10.10.1 Saudi Arabia
    • 10.10.2 UAE
    • 10.10.3 Qatar
    • 10.10.4 South Africa
    • 10.10.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Allergan Corporation
  • 12.2 Sanofi Corporation
  • 12.3 Evonik Industries AG
  • 12.4 Bloomage Biotechnology Corporation Limited
  • 12.5 Seikagaku Corporation
  • 12.6 Anika Therapeutics, Inc.
  • 12.7 LG Chem
  • 12.8 Lubrizol Corporation
  • 12.9 Royal DSM
  • 12.10 Kewpie Corporation
  • 12.11 Symatese Group
  • 12.12 HTL Biotechnology
  • 12.13 FocusChem Biotech
  • 12.14 Croda International Plc
  • 12.15 Stanford Chemicals Company
  • 12.16 Maruha Nichiro Corporation
  • 12.17 Evolus, Inc.
  • 12.18 Contipro a.s.
  • 12.19 Fidia Farmaceutici S.p.A.
  • 12.20 Zimmer Biomet

List of Tables

  • Table 1 Global Hyaluronic Acid Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Hyaluronic Acid Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Hyaluronic Acid Market Outlook, By High Molecular Weight Hyaluronic Acid (2022-2030) ($MN)
  • Table 4 Global Hyaluronic Acid Market Outlook, By Medium Molecular Weight Hyaluronic Acid (2022-2030) ($MN)
  • Table 5 Global Hyaluronic Acid Market Outlook, By Low Molecular Weight Hyaluronic Acid (2022-2030) ($MN)
  • Table 6 Global Hyaluronic Acid Market Outlook, By Formulation (2022-2030) ($MN)
  • Table 7 Global Hyaluronic Acid Market Outlook, By Injectable (2022-2030) ($MN)
  • Table 8 Global Hyaluronic Acid Market Outlook, By Topical (2022-2030) ($MN)
  • Table 9 Global Hyaluronic Acid Market Outlook, By Oral (2022-2030) ($MN)
  • Table 10 Global Hyaluronic Acid Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 11 Global Hyaluronic Acid Market Outlook, By E-commerce Platforms (2022-2030) ($MN)
  • Table 12 Global Hyaluronic Acid Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
  • Table 13 Global Hyaluronic Acid Market Outlook, By Pharmacies & Drug Stores (2022-2030) ($MN)
  • Table 14 Global Hyaluronic Acid Market Outlook, By Specialty Stores (2022-2030) ($MN)
  • Table 15 Global Hyaluronic Acid Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
  • Table 16 Global Hyaluronic Acid Market Outlook, By Application (2022-2030) ($MN)
  • Table 17 Global Hyaluronic Acid Market Outlook, By Food & Dietary Supplements (2022-2030) ($MN)
  • Table 18 Global Hyaluronic Acid Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 19 Global Hyaluronic Acid Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 20 Global Hyaluronic Acid Market Outlook, By Pharmaceuticals (2022-2030) ($MN)
  • Table 21 Global Hyaluronic Acid Market Outlook, By Personal Care & Beauty (2022-2030) ($MN)
  • Table 22 Global Hyaluronic Acid Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Hyaluronic Acid Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Hyaluronic Acid Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 25 Global Hyaluronic Acid Market Outlook, By Aesthetic Clinics (2022-2030) ($MN)
  • Table 26 Global Hyaluronic Acid Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
  • Table 27 Global Hyaluronic Acid Market Outlook, By Research Institutions (2022-2030) ($MN)
  • Table 28 Global Hyaluronic Acid Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.